AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionLcnb Corp
Latest Disclosed Ownership7,923 shares
Latest Disclosed Value $ 1,723,274
Lcnb Corp reports 6.61% increase in ownership of 4AB / AbbVie Inc.

On May 11, 2026 - Lcnb Corp filed a 13F-HR form disclosing ownership of 7,923 shares of AbbVie Inc. (BG:4AB) valued at $1,723,274 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 10, 2026 disclosing 7,432 shares of AbbVie Inc.. This represents a change in shares of 6.61% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F Abbvie Common Stock 00287Y109 7,923 491 6.61 1,723 1.47 0.5793
2026-02-10 2025-12-31 13F Abbvie Common Stock 00287Y109 7,432 -50 -0.67 1,698 -1.96 0.5690
2025-11-10 2025-09-30 13F Abbvie Common Stock 00287Y109 7,482 0 0.00 1,732 24.78 0.6062
2025-08-11 2025-06-30 13F Abbvie Common Stock 00287Y109 7,482 0 0.00 1,389 -11.42 0.4886
2025-05-12 2025-03-31 13F Abbvie Common Stock 00287Y109 7,482 183 2.51 1,568 20.82 0.5772
2025-02-11 2024-12-31 13F Abbvie Common Stock 00287Y109 7,299 38 0.52 1,297 -9.49 0.4729
2024-11-12 2024-09-30 13F Abbvie Common Stock 00287Y109 7,261 0 0.00 1,434 15.10 0.5079
2024-08-14 2024-06-30 13F Abbvie Common Stock 00287Y109 7,261 0 0.00 1,245 -5.82 0.4653
2024-05-10 2024-03-31 13F Abbvie Common Stock 00287Y109 7,261 -12 -0.16 1,322 17.30 0.4784
2024-02-12 2023-12-31 13F Abbvie Common Stock 00287Y109 7,273 53 0.73 1,127 4.74 0.4432
2023-11-13 2023-09-30 13F Abbvie Common Stock 00287Y109 7,220 -500 -6.48 1,076 3.46 0.4761
2023-08-14 2023-06-30 13F Abbvie Common Stock 00287Y109 7,720 175 2.32 1,040 -13.48 0.4436
2023-05-03 2023-03-31 13F Abbvie Common Stock 00287Y109 7,545 -375 -4.73 1,202 -6.02 0.5439
2023-02-10 2022-12-31 13F Abbvie Common Stock 00287Y109 7,920 110 1.41 1,280 22.04 0.5943
2022-11-14 2022-09-30 13F Abbvie Common Stock 00287Y109 7,810 0 0.00 1,048 -12.37 0.5695
2022-08-12 2022-06-30 13F Abbvie Common Stock 00287Y109 7,810 569 7.86 1,196 1.87 0.6200
2022-05-13 2022-03-31 13F Abbvie Common Stock 00287Y109 7,241 992 15.87 1,174 38.77 0.5516
2022-02-14 2021-12-31 13F Abbvie Common Stock 00287Y109 6,249 177 2.92 846 29.16 0.3867
2021-11-12 2021-09-30 13F Abbvie Common Stock 00287Y109 6,072 0 0.00 655 -4.24 0.3307
2021-08-13 2021-06-30 13F Abbvie Common Stock 00287Y109 6,072 0 0.00 684 4.11 0.3441
2021-05-13 2021-03-31 13F Abbvie Common Stock 00287Y109 6,072 50 0.83 657 1.86 0.3581
2021-02-12 2020-12-31 13F Abbvie Common Stock 00287Y109 6,022 -75 -1.23 645 20.79 0.3655
2020-11-12 2020-09-30 13F Abbvie Common Stock 00287Y109 6,097 -207 -3.28 534 -13.73 0.3491
2020-08-12 2020-06-30 13F Abbvie Common Stock 00287Y109 6,304 -76 -1.19 619 27.37 0.4181
2020-05-11 2020-03-31 13F Abbvie Common Stock 00287Y109 6,380 550 9.43 486 -5.81 0.3794
2020-02-10 2019-12-31 13F ABBVIE Common Stock 00287Y109 5,830 -100 -1.69 516 14.92 0.3149
2019-11-08 2019-09-30 13F ABBVIE Common Stock 00287Y109 5,930 252 4.44 449 8.72 0.2877
2019-08-01 2019-06-30 13F ABBVIE Common Stock 00287Y109 5,678 -62 -1.08 413 -10.80 0.2899
2019-05-02 2019-03-31 13F ABBVIE Common Stock 00287Y109 5,740 -18 -0.31 463 -12.81 0.3351
2019-02-19 2018-12-31 13F ABBVIE Common Stock 00287Y109 5,758 11 0.19 531 -2.39 0.4382
2018-11-09 2018-09-30 13F ABBVIE Common Stock 00287Y109 5,747 -180 -3.04 544 -0.91 0.3843
2018-08-13 2018-06-30 13F ABBVIE Common Stock 00287Y109 5,927 309 5.50 549 3.39 0.4957
2018-05-15 2018-03-31 13F ABBVIE Common Stock 00287Y109 5,618 10 0.18 531 -2.03 0.4776
2018-02-13 2017-12-31 13F ABBVIE Common Stock 00287Y109 5,608 -100 -1.75 542 6.90 0.4773
2017-11-13 2017-09-30 13F ABBVIE Common Stock 00287Y109 5,708 -130 -2.23 507 19.86 0.4759
2017-08-14 2017-06-30 13F ABBVIE Common Stock 00287Y109 5,838 -100 -1.68 423 9.30 0.4135
2017-05-12 2017-03-31 13F ABBVIE Common Stock 00287Y109 5,938 -50 -0.84 387 3.20 0.3701
2017-02-14 2016-12-31 13F ABBVIE Common Stock 00287Y109 5,988 5,988 375 0.3705
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.